Abstract-The administration of the convulsant, L-methionine-dl-sulfoximine (MSO), increased histamine N-methyl transferase (E.C. 2.1.1.8) (HMT) activity in rat and mouse brain and, to a lesser extent, catechol-O-methyl transferase (E.C. 2.1.1.6) (COMT) activity in rat brain. The duration of this effect was shortened by co-administration of L-methionine. The increased HMT activity was seen in S or 7 rat brain regions tested. L-Methionine administration had no effect on the activity of either enzyme. Partially purified HMT preparations from rat or guinea-pig brain exhibited no alterations in activity after the in uitro addition of MSO or L-methionine over a wide rangc of histamine and S-adenosyl-Lmethionine concentrations. Rat brain COMT was equally unaffected by MSO and L-methionine. The in uitro inhibition of HMT and COMT by S-adenosyl-L-homocysteine was the same whether tested on preparations derived from MSO-treated or control animals. The data are discussed with respect to the possible involvbnent of aberrant methylation processes in the MSO-induccd seizure. (1967) described an increase of the cerebral catechol-0-methyl transferase activity (E.C. 2.1.1.6) (COMT) after MSO, a n observation which we undertook to explore in more detail, together with a n examination of the effect of MSO on another methyl transferase enzyme of brain tissue, namely histamine-N-methyl transferase (E.C. 2.1.1.8) (HMT). The present report describes findings which lend support to the premise of an effect of MSO on the utilization of SAM, as evidenced by the selective elevation of HMT in mouse and rat brain after MSO, and, more specifically, in 5 out of 7 rat brain neuroanatomical regions. In addition, our results confirm and extend the original observation (DE ROBERTIS et a/., 1967) that MSO affects COMT in vivo and they also show that neither methyl transferase-stimulating effect of MSO is reversed when L-methionine is administered jointly with MSO. A preliminary report has appeared (SCHATZ et al., 1974a) .
& KOLOUSEK, 1958; SELLINGER et al., 1968) , and, more recently, we demonstrated that the MSO-induced depletion of cerebral SAM is also preventcd under these conditions (SCHATZ & SELLINGER, 1975) . Two possible mechanisms which may account for the observed depletion of the SAM levels in brain after MSO are (a) an inhibition of the synthesis of SAM via an effect of MSO on ATP: L-methionine-S-adenosyl transferase (E.C. 2.5.1.6) and (b) a stimulation of the utilization of SAM by one or by several members of the large family of cerebral methyl transferase enzymes. Studies from our laboratory (SCHATZ et al., 1973) have indicated that MSO fails to affect the synthesis of SAM either in vivo or in vitro, a finding which agrees with the observations of L~MBARDINI et al. (1970) , who noted that MSO serves neither as a substrate nor as an inhibitor of the hepatic ATP:
L-methionine-S-adenosyl transferase. In line with the Supported by grants from the United States Public Health Service MH 07417, NS 06294 and a grant from the Epilepsy Foundation of America.
Abbreviations used: MSO: L-Methionine-dl-sulfoximine.
HMT: histamine-N-methyl transferase. COMT: catechol-0-methyl transferase. SAM: S-adenosyl-L-methionine. SAH: S-adenosyl-L-homocysteine. second of the above alternatives, DE RORFRTIS et a/.
(1967) described an increase of the cerebral catechol-0-methyl transferase activity (E.C. 2.1.1.6) (COMT) after MSO, a n observation which we undertook to explore in more detail, together with a n examination of the effect of MSO on another methyl transferase enzyme of brain tissue, namely histamine-N-methyl transferase (E.C. 2.1.1.8) (HMT). The present report describes findings which lend support to the premise of an effect of MSO on the utilization of SAM, as evidenced by the selective elevation of HMT in mouse and rat brain after MSO, and, more specifically, in 5 out of 7 rat brain neuroanatomical regions. In addition, our results confirm and extend the original observation (DE ROBERTIS et a/., 1967) that MSO affects COMT in vivo and they also show that neither methyl transferase-stimulating effect of MSO is reversed when L-methionine is administered jointly with MSO. A preliminary report has appeared (SCHATZ et al., 1974a) .
MATERIAL AND METHODS

Animals
Adult male Sprague-Dawley rats (120-2OOg) and adult male Swiss Webster mice (25-32g) homogenates were centrifuged at 50,ooOg for 10min. Aliquots of these supernatants were assayed for HMT or COMT activity (see below).
Tissue preparation for in vitro experiments
Whole rat or mouse brain was homogenized in 5-10 vol. of icecold 0.32 M sucrose or saline-Triton X-100 (@l%) and 50,ooOg supernatants were prepared as described in the above section. For some experiments, HMT was partially purified from rat or guinea-pig brain by the procedure of BROWN et al. (1959) .
Analytical
COMT was determined according to MCCAMAN (1963) as modified by PORCHER & HELLER (1972) with 3,4-dihydroxybenzoic acid as substrate. After a 30min. incubation period the reaction was stopped by the addition of 0.2 ml of 3 M HCI. Ethyl acetate (6ml) was added, the tubes shaken for lOmin, centrifuged at 2000rev./min (GLC-1, Sorvall, Inc., Newton, Connecticut) for 10min and 4ml aliquots of the organic phase were used to measure radioactivity. The reaction product migrated identically with authentic 3-[methyl-'4C]methoxy-4-hydroxybenzoic acid on silica gel TLC plates in benzene:propionic acid:-water (2: 2: 1) (ARMSTRONG et al., 1956 ). Compounds were identilied by means of diazotized sulfanilic acid spray (Arms & MITCHELL, 1952) , ninhydrin (025% in acetone) spray and the ultraviolet quenching reaction (SALVATORE et nl., 1971). Recovery of 3-[methyl-'4C]methoxy-4-hydroxybenzoic acid from ethyl acetate was 85%. HMT was assayed according to SNYDER & AXELROD (1965) . Authentic [methyl-i4C]methylhi~tamine was prepared by this method, and routinely 10-M histamine was used in the assay, higher concentrations proving strongly inhibitory. The concentration of SAM was 3.2 x lo-' M. The nature of the product was investigated and found to be identical with 1-methylhistamine, by cochromatography with the authentic substance using silica gel TLC or paper (Whatman No. 1) chromatography in ethanol:20% ammonia:-water (10: 1 : l), ethano1:diethyl ether:25% ammonia:water (8:10:1:2) and n-butano1:ethyl acetate:water (1:l:l).
Compounds were identified using the ultra-violet quenching reaction and ninhydrin (0.25% in acetone) or iodine (1% in ethanol) sprays. The recovery of [methyl-'4C]methylhistamine from the organic phase was 50%. All enzyme activity values were corrected accordingly. For counting, 4 ml aliquots of the organic phase were transferred to vials containing 2 mi of ethanol and 10 ml of scintillant (0.4% PPO and 0.01% dimethyl POPOP in toluene) and the radioactivity was measured in a liquid scintillation counter (Unilux 11, Nuclear Chicago). Counting efficiency was determined by the channels ratio technique.
Protein was measured in triplicate by the method of LOWRY et al. (1951) using bovine serum albumin as the protein standard.
Statistical analysis
Statistical differences between drug-treated groups and corresponding saline-treated animals were evaluated by the Student t-test.
RESULTS
The effect of MSO on HMT in vivo
The administration of MSO produced a timedependent increase of whole brain HMT specific activity which was maximal (25%) at 6 h ( Fig. 1) . HMT activity was also significantly increased at 1 and 3 h after MSO as well as after MSO + L-methionine, but not after L-methionine alone. Since the HMT activity of rat brain is much lower than that of mouse brain (SCHAYER & REILLY, 1973), it appeared possible that the effect of MSO on HMT could only be demonstrable in a species with low HMT activity. To test this, mouse brain HMT was assayed 1, 3 and 6 h after MSO and, as was true for rat brain, a timerelated increase of its specific activity, with a maximum of 20% at 6 h, was demonstrated (Fig. 2) .
The previously uncovered regional specificity of the MSO-induced depletion of cerebral SAM levels , 1975) prompted us to examine the possibility of a similar regional specificity of the MSO effect on rat brain HMT. Table 1 shows that the specific activity of HMT in control brains varied over a 5-fold range from a low of 0.63 nmol of methylhistamine/mg of protein/h in the cerebellum to a high of 3.00 mpmole of methylhistamine/mg of protein/h in the hypothalamus. While no significant effects of MSO were noted at I h, HMT activity was significantly increased in all regions except the midbrain and the hypothalamus at 3 h. At 6 h the MSO-elicited increase remained significant in the cerebellum, the brainstcm, the cerebral cortex and the hippocampus, while it ceased to be significant in the striatum (Fig.  3) .
The effect of MSO on COMT in vivo
The results of an investigation of the effects of MSO on whole rat brain COMT activity are shown in Fig. 4 . The activity was moderately, albeit significantly (8%), increased at 3 h. Thc joint administration of MSO + L-methionine also increased COMT activity at 1 and 3 h: whereas, as was the case with HMT, injections of L-methionine alone had no effect (Fig.  4 ).
Attempts to demonstrate effects on HMT in vitro
Two scts of experiments were conducted. (A) HMT was purified from untreated rat or guinea-pig brains and the effect of several substances on its activity was tested. (B) HMT was purified in parallel from untreated rats and from animals injected with a convulsant dose of MSO 3 h prior to death and the effects of a numbcr of substances on both activities were compared in vitro.
(A) The following negative findings were made:
MSO (10 x -' M -10 x -' M) had no effect on partially purified (%fold) guinea-pig or rat ( 4 5 cause marked and region-specific reductions of cerebral SAM levels (SCHATZ & SELLINGER, 1975) alsb results in a time-dependent elevation of the specific activities of two cerebral methyltransferases, HMT and COMT (Figs. 1-4) . Of interest was the finding that the elevation of HMT occurred only in those brain regions in which the specific activity of HMT was below a value of 2.75 (Table I) , i.e. it did not involve the midbrain and the hypothalamus. The HMT specific activity values reported in Table 1 (Fig. 3) reveals that in both instances the hypothalamus and the midbrain remained largely unaffected, while, on the contrary, all other and COMT (DEGUCHI & BAKCHAS, 1971 ; CQWARD et al., 1972) ; we reasoned therefore that MSO may be effective in altering the sensitivity of these enzymes toward SAH in uitro. Our efforts to gain evidence for this supposition were unsuccessful, however, as we found no circumstances under which HMT and COMT inhibition by SAH could be diminished by MSO. As a result, it is difficult to reconcile the in uitro and the in vivo findings, as depicted in Figs. 1 4 , except by assuming that the MSO effect in uivo is indirect and dependent on the structural integrity of the tissue and the intactness of membrane-bound intracellular compartments housing molecules such as SAM (JUDES & JACOB, 1972) , SAH, HMT (SNYDEK et al., 1974) and COMT (PORCHER & HELLEK, 1972) .
We have considered two other explanations for the observed MSO-induced increase of HMT: (1) MSO elicits the methylation of histamine to N-methyland/or NN-dimethylhistamine, two known activators of HMT in uitro (BAKTH et al., 1973) , N-methylhistamine, in addition, serving as a substrate for the HMT of the pig antrum mucosa (BARTH et al., 1973) . A preliminary search for these substances has not been successful to date as no evidcnce for their formation in uitro by the HMT of MSO-treated, but not by that of control animals, could be obtained. The alternate possibility, namely the formation of Nmethylhistamine and N',N'-dimethylhistamine in brain after MSO remains-to be tested. (2) MSO causes an accelerated metabolism of SAH via activation of adenosylhomocysteinase (S-adenosylhomocysteine hydrolase, E.C. 3.3.1.1), an enzyme known to be engaged in the regulation of several other methyl transferases including hepatic COMT (DEGUCHI & BARCHAS, 1971) . Brains of MSO-treated animals would thus contain less than normal amounts of SAH, the regulation of HMT levels by SAH would be temporarily relieved and hence HMT activity levels would rise to the observed higher than normal values.
It is tempting to extend the relevance of the above considerations to help explain thc convulsant properties of MSO. It is possible that 'abnormal' methylated substances such as, for example, N-methyl-and/or N',N'-dimethylhistamine or other as yet unidentified methylated amines may be the actual causative agents of the seizure. Alternatively, if increased breakdown of excess SAH is involvcd as a mechanism to return the MSO-perturbed cellular SAM/SAH ratios to control values, homocysteine, a convulsant agent whose action results in MSO-like seizures (SPRINCE et al., 1969) , and/or homocysteic acid, a powerful CNS excitant (CURTIS et a/., 1972) could be produced at selected sensitive sites in amounts sufficient to trigger uncontrolled neuronal firing.
